Your account is not claimed yet. You can sign up with ORCID to claim your account.

Spencer Thomas Lea (Spencer T Lea)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Dendritic Cells

Dna Damage Response

Top Venues

Science immunology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Casey R Ager, Akash Boda, Kimal Rajapakshe, Spencer Thomas Lea, Maria Emilia Di Francesco, Priyamvada Jayaprakash, Ravaen B Slay, Brittany Morrow, Rishika Prasad, Meghan A Dean, Colm R Duffy, Cristian Coarfa, Philip Jones, Michael A Curran
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for immunotherapy of cancer 9 (8) (2022)
Rodney Cheng-En Hsieh, Krishnan Sunil, Ren-Chin Wu, Akash R Boda, Arthur J Liu, Michelle Winkler, Wen-Hao Hsu, Steven Hsesheng Lin, Mien-Chie Hung, Li-Chuan Chan, Krithikaa Rajkumar Bhanu, Anupallavi Srinivasamani, Ricardo Alexandre De Azevedo, Yung-Chih Chou, Ronald A DePinho, Matthew M Gubin, Eduardo Vilar, Chao-Hsien Chen, Ravaen Slay, Priyamvada Jayaprakash, Shweta Mahendra Hegde, Genevieve Hartley, Spencer Thomas Lea, Rishika Prasad, Brittany Morrow, Coline Agnes Couillault, Madeline Steiner, Chun-Chieh Wang, Bhanu Prasad Venkatesulu, Cullen M Taniguchi, Yon Son Betty Kim, Junjie Chen, Nils-Petter Rudqvist, Michael A Curran
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Science immunology 7 (72) (2022)